Peter S. Roddy
Plus aucun poste en cours
Historique de carrière de Peter S. Roddy
Anciens postes connus de Peter S. Roddy
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CYTOKINETICS, INCORPORATED | Comptroller/Controller/Auditor | 03/04/2017 | 15/05/2019 |
| CASSAVA SCIENCES, INC. | Directeur Financier/CFO | 01/11/2002 | 09/03/2017 |
| ASPIRA WOMEN'S HEALTH INC. | Directeur/Membre du Conseil | 01/02/2010 | 16/06/2016 |
| Independent Dir/Board Member | 01/02/2010 | 16/06/2016 | |
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Directeur Financier/CFO | 01/01/2002 | 01/01/2012 |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Directeur/Membre du Conseil | 22/10/2010 | - |
Formation de Peter S. Roddy
| University of California, Berkeley | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Director of Finance/CFO | 2 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CASSAVA SCIENCES, INC. | Health Technology |
| ASPIRA WOMEN'S HEALTH INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| Entreprise privées | 2 |
|---|---|
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Health Technology |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Commercial Services |
- Bourse
- Insiders
- Peter S. Roddy
- Expérience
